You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lisdexamfetamine Dimesylate

Showing 1 - 25 of 103
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Childhood Trial in Minneapolis (Lisdexamfetamine Dimesylate, Lifestyle therapy)

Not yet recruiting
  • Obesity, Childhood
  • Lisdexamfetamine Dimesylate
  • Lifestyle therapy
  • Minneapolis, Minnesota
    University of Minnesota
Sep 1, 2022

ADHD Trial in London (Lisdexamfetamine dimesylate, Guanfacine Extended Release Oral Tablet, Placebo)

Active, not recruiting
  • ADHD
  • Lisdexamfetamine dimesylate
  • +2 more
  • London, United Kingdom
    Institute of Psychiatry, Psychology & Neuroscience; King's Colle
Aug 16, 2022

Bariatric Surgery and Pharmacokinetics of Lisdexamphetamine

Recruiting
  • Obesity, Morbid
  • Lisdexamfetamine Dimesylate
  • Trondheim, Norway
    St. Olavs University Hospital
Apr 28, 2022

Loss-of-control Eating, Obesity/Overweight Trial in New Haven (Lisdexamfetamine Dimesylate (Medication), Placebo)

Enrolling by invitation
  • Loss-of-control Eating
  • Obesity/Overweight
  • Lisdexamfetamine Dimesylate (Medication)
  • Placebo
  • New Haven, Connecticut
    Yale School of Medicine
Oct 4, 2022

Attention Deficit Disorder With Hyperactivity Trial in Buffalo (Lisdexamfetamine Dimesylate 40 MG, Placebo)

Completed
Has Results
  • Attention Deficit Disorder With Hyperactivity
  • Lisdexamfetamine Dimesylate 40 MG
  • Placebo
  • Buffalo, New York
    SUNY at Buffalo
Jun 2, 2021

ADHD, Autism Spectrum Disorder Trial in Ottawa (Lisdexamfetamine Dimesylate)

Recruiting
  • Attention Deficit Hyperactivity Disorder
  • Autism Spectrum Disorder
  • Lisdexamfetamine Dimesylate
  • Ottawa, Ontario, Canada
    Center for Pediatric Excellence
Mar 28, 2022

Attention-Deficit Hyperactivity Disorder Trial in Houston (Lisdexamfetamine Dimesylate (LDX), Immediate Release Mixed

Completed
Has Results
  • Attention-Deficit Hyperactivity Disorder
  • Lisdexamfetamine Dimesylate (LDX)
  • +2 more
  • Houston, Texas
    Claghorn-Lesem Research Clinic
Jun 8, 2021

Binge-Eating Disorder, Obesity Trial in New Haven (Lisdexamfetamine Dimesylate, Placebo)

Recruiting
  • Binge-Eating Disorder
  • Obesity
  • Lisdexamfetamine Dimesylate
  • Placebo
  • New Haven, Connecticut
    Yale Department of Psychiatry
Jan 6, 2022

Schizophrenia Trial in Irving (SPD489 40mg, SPD489 100mg, SPD489 160mg)

Terminated
Has Results
  • Schizophrenia
  • SPD489 40mg
  • +3 more
  • Irving, Texas
    University Hills Clinical Research
May 29, 2021

Binge-Eating Disorder, Obesity Trial in New Haven (drug, behavioral, other)

Recruiting
  • Binge-Eating Disorder
  • Obesity
  • Lisdexamfetamine Dimesylate
  • +2 more
  • New Haven, Connecticut
    Yale Department of Psychiatry
Jan 6, 2022

ADHD Trial in United States (Vyvanse (lisdexamfetamine dimesylate), Placebo)

Completed
Has Results
  • ADHD
  • Vyvanse (lisdexamfetamine dimesylate)
  • Placebo
  • Little Rock, Arkansas
  • +8 more
Jun 9, 2021

The Day-time Response Variation of (Lis)Dexamphetamine

Recruiting
  • Adhd
  • Dexamfetamine Sulfate 5 Mg Oral Tablet
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
    ADHDcentraal
Sep 15, 2021

Healthy Trial in Miami (LDX + Venlafaxine XR, Venlafaxine XR + LDX)

Completed
Has Results
  • Healthy
  • LDX + Venlafaxine XR
  • Venlafaxine XR + LDX
  • Miami, Florida
    Clinical Pharmacology of Miami
Jun 8, 2021

Schizophrenia Trial in Glendale, Long Beach (SPD489 (Lisdexamfetamine dimesylate), Placebo)

Completed
Has Results
  • Schizophrenia
  • SPD489 (Lisdexamfetamine dimesylate)
  • Placebo
  • Glendale, California
  • +1 more
May 13, 2021

Negative Symptoms of Schizophrenia Trial (SPD489 Low-Dose, SPD489 High-Dose, Placebo)

Withdrawn
  • Negative Symptoms of Schizophrenia
  • SPD489 Low-Dose
  • +2 more
  • (no location specified)
Jun 1, 2021

Bulimia Nervosa Trial in Halifax (Lisdexamfetamine dimesylate)

Terminated
  • Bulimia Nervosa
  • Lisdexamfetamine dimesylate
  • Halifax, Nova Scotia, Canada
    Nova Scotia Health Authority
Nov 25, 2020

ADHD (ADHD) Trial in United States (Vyvanse (lisdexamfetamine dimesylate))

Completed
Has Results
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • Vyvanse (lisdexamfetamine dimesylate)
  • Scottsdale, Arizona
  • +45 more
Feb 25, 2022

Binge Eating, Eating Behavior Trial in Birmingham (Placebo oral tablet, Lisdexamfetamine Dimesylate)

Terminated
  • Binge Eating
  • Eating Behavior
  • Placebo oral tablet
  • Lisdexamfetamine Dimesylate
  • Birmingham, United Kingdom
    University of Birmingham
Nov 4, 2020

Healthy Trial in Boston (Lisdexamfetamine Dimesylate, Racemic mixture of dextroamphetamine and lisdexamfetamine)

Terminated
Has Results
  • Healthy
  • Lisdexamfetamine Dimesylate
  • Racemic mixture of dextroamphetamine and lisdexamfetamine
  • Boston, Massachusetts
    Massachusetts General Hospital
May 25, 2021

Schizophrenia Trial in United States (SPD489 low dose range (40mg, 80mg, and 100mg), SPD489 high dose range (120mg, 140mg and

Terminated
Has Results
  • Schizophrenia
  • SPD489 low dose range (40mg, 80mg, and 100mg)
  • +2 more
  • Miami Springs, Florida
  • +3 more
May 29, 2021

Healthy Volunteers Trial in Miami (Lisdexamfetamine Dimesylate)

Completed
Has Results
  • Healthy Volunteers
  • Lisdexamfetamine Dimesylate
  • Miami, Florida
    Clinical Pharmacology of Miami, Inc
May 13, 2021

Healthy Volunteers Trial in Miami (Lisdexamfetamine Dimesylate, Adderall XR (mixed salts amphetamine))

Completed
Has Results
  • Healthy Volunteers
  • Lisdexamfetamine Dimesylate
  • Adderall XR (mixed salts amphetamine)
  • Miami, Florida
    Clinical Pharmacology of Miami, Inc.
Jun 8, 2021

Schizophrenia Trial in Oklahoma City, Philadelphia (SPD489)

Terminated
Has Results
  • Schizophrenia
  • Oklahoma City, Oklahoma
  • +1 more
May 29, 2021

Attention-Deficit/Hyperactivity Disorder Trial in Worldwide (Lisdexamfetamine Dimesylate, Atomoxetine Hydrochloride)

Completed
Has Results
  • Attention-Deficit/Hyperactivity Disorder
  • Lisdexamfetamine Dimesylate
  • Atomoxetine Hydrochloride
  • Dothan, Alabama
  • +63 more
Jun 1, 2021

ADHD Trial in Worldwide (Lisdexamfetamine Dimesylate (LDX), Methylphenidate Hydrochloride, Placebo)

Completed
Has Results
  • ADHD
  • Lisdexamfetamine Dimesylate (LDX)
  • +2 more
  • Hoboken, Antwerp, Belgium
  • +48 more
Jun 9, 2021